Mankind Pharma’s promoters have divested a 1.62 per cent stake in the company for Rs 1,367 crore through open market transactions. According to the block deal data available with the NSE, promoters Sheetal Arora, Puja Juneja, and Arjun Juneja offloaded a total of 64,89,534 shares in two tranches each, representing a 1.62 per cent stake in Mankind Pharma, on the NSE.
The shares were disposed of at an average price of Rs 2,107.35 apiece, taking the combined deal value to Rs 1,367.57 crore. Through the latest transaction, the combined shareholding of promoter and promoter group entities have declined to 74.88 per cent stake from 76.50 per cent stake holding (as of December quarter) in Mankind Pharma.
As per market regulations, all listed companies must maintain a minimum public shareholding of 25 per cent, while newly-listed firms are given three years to meet the requirement of 25 per cent public float. Accordingly, after the stake sale, the company has complied with the norms with 25 per cent minimum public shareholding rules.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |